Suppression of melanogenesis by induction of endogenous intracellular metallothionein in human melanocytes.
Nitric oxide (NO) is a potent intercellular mediator of melanogenesis, whereas metallothionein (MT) is an inducible intracellular antioxidant that has been reported to scavenge NO. We investigated the existence and induction of MT in melanocytes, and its inhibitory effect on NO-induced melanogenesis. The expression of MT was detected in melanocytes, however, at a lower level than in keratinocytes, and its induction was possible by the addition of zinc chloride. Further, an NO-stimulated increase of tyrosinase activity in melanocytes was remarkably suppressed, when MT was induced prior to NO stimulation. Melanogenesis was also suppressed, when dexamethasone was used to induce MT. However, an NO-stimulated increase of tyrosinase expression was not suppressed at the gene and protein level, when MT was induced in melanocytes. The same suppressive effect of melanogenesis was also observed, when alpha-melanocyte-stimulating hormone or endothelin-1 was used as a stimulator. Because these results implied a mechanism other than NO scavenging to explain the suppressive effect of MT induction on melanogenesis, the direct inhibition of tyrosinase by MT was examined. Melanosome fractions were prepared from melanocytes, whose melanogenesis was suppressed by the induction of MT. Tyrosinase suppression was observed in the melanosome fractions, which was neutralized by the addition of anti-MT antibody. These results suggest that MT induction may be effective to suppress melanogenesis stimulated by NO as well as other melanogens, and these suppressive effects might be due to a direct inhibition of tyrosinase activity in melanosome and not a scavenging effect of NO.
Sasaki
M
M
Basic Research Laboratory, Kanebo Ltd, Odawara, Kanagawa, Japan. msasaki@oda.cos.kanebo.co.jp
Kizawa
K
K
Igarashi
S
S
Horikoshi
T
T
Uchiwa
H
H
Miyachi
Y
Y
D015152:Blotting, Northern; D015153:Blotting, Western; D002712:Chlorides / Q000378:metabolism / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D019332:Endothelin-1 / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D005938:Glucocorticoids / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D015603:Keratinocytes / Q000378:metabolism; D008544:Melanocytes / Q000378:metabolism*; D020460:Melanosomes / Q000378:metabolism; D008668:Metallothionein / Q000378:metabolism* / Q000502:physiology*; D014442:Monophenol Monooxygenase / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors; D017967:Zinc Compounds / Q000378:metabolism / Q000494:pharmacology; D000521:alpha-MSH / Q000378:metabolism
D002712:Chlorides; D019332:Endothelin-1; D005938:Glucocorticoids; D012333:RNA, Messenger; D017967:Zinc Compounds; D009569:Nitric Oxide; D000521:alpha-MSH; D003907:Dexamethasone; C016837:zinc chloride; D008668:Metallothionein; D014442:Monophenol Monooxygenase